|
Market Closed -
Nasdaq
07:00:00 17/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 25.87 USD | -2.08% |
|
+0.23% | -3.40% |
| 19/08 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 07/08 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Börse Stuttgart
| 29A | Delayed | |
|
Boerse Muenchen
| 29A | Real-time | |
|
Tradegate
| 29A | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 27.39 | 27.39 | 29.26 |
| Spread/Res. | -5.55% | -5.55% | -11.59% |
| Spread/Supp. | +2.99% | +20.21% | +53.35% |
| Support | 25.12 | 21.52 | 16.87 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMPH Stock
- Charts Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
